These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16790574)
1. Tigecycline: place in therapy and important considerations. Garrelts JC; Schroeder T Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574 [No Abstract] [Full Text] [Related]
2. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines]. Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033 [No Abstract] [Full Text] [Related]
3. Tigecycline: a review of a new glycylcycline antibiotic. Scheinfeld N J Dermatolog Treat; 2005; 16(4):207-12. PubMed ID: 16249141 [TBL] [Abstract][Full Text] [Related]
4. Tigecycline: a new glycylcycline antimicrobial agent. Kasbekar N Am J Health Syst Pharm; 2006 Jul; 63(13):1235-43. PubMed ID: 16790575 [TBL] [Abstract][Full Text] [Related]
5. New antibiotic approved for MRSA. Senior K Lancet Infect Dis; 2005 Aug; 5(8):474. PubMed ID: 16094734 [No Abstract] [Full Text] [Related]
6. Re-defining tigecycline therapy. De Rosa FG; Corcione S; Di Perri G; Scaglione F New Microbiol; 2015 Apr; 38(2):121-36. PubMed ID: 25915055 [TBL] [Abstract][Full Text] [Related]
7. Tigecycline: a single antibiotic for polymicrobial infections. Pankey GA; Steele RW Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711 [No Abstract] [Full Text] [Related]
8. EUCAST technical note on tigecycline. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee Clin Microbiol Infect; 2006 Nov; 12(11):1147-9. PubMed ID: 17063597 [No Abstract] [Full Text] [Related]
9. Tigecycline: benefits and risks. Cai Y; Wang R Lancet Infect Dis; 2011 Nov; 11(11):804-5. PubMed ID: 21784707 [No Abstract] [Full Text] [Related]
10. Effectiveness and safety of tigecycline: focus on use for approved indications. Vardakas KZ; Rafailidis PI; Falagas ME Clin Infect Dis; 2012 Jun; 54(11):1672-4. PubMed ID: 22431809 [No Abstract] [Full Text] [Related]
11. [Tigecycline: 10 years of history and still in full force]. Barberán J; Salso S; Alhambra A Rev Esp Quimioter; 2015 Apr; 28(2):61-78. PubMed ID: 25904513 [No Abstract] [Full Text] [Related]
12. [Tigecycline--a new antibiotic]. Skibeli V; Aaløkken I; Lingaas E; Midtvedt T; Solberg CO; Melby KK Tidsskr Nor Laegeforen; 2010 Aug; 130(16):1624-6. PubMed ID: 20805861 [TBL] [Abstract][Full Text] [Related]
13. [Bacterial resistance and a new antibiotic: tigecycline]. Gobernado M Rev Esp Quimioter; 2006 Sep; 19(3):209-19. PubMed ID: 17099789 [No Abstract] [Full Text] [Related]
15. Tigecycline: an antibiotic for the twenty-first century. Dryden M J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii3-4. PubMed ID: 23772044 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline. Falagas ME; Karageorgopoulos DE; Dimopoulos G Curr Drug Metab; 2009 Jan; 10(1):13-21. PubMed ID: 19149509 [TBL] [Abstract][Full Text] [Related]
17. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation. Nix DE; Matthias KR J Antimicrob Chemother; 2010 Jun; 65(6):1311-2. PubMed ID: 20378673 [No Abstract] [Full Text] [Related]
18. [Experience with tigecycline in the treatment of multiresistant germs in the ICU]. Curiel Balsera E; Poullet Brea AM; Prieto Palomino MÁ Med Intensiva; 2011; 35(5):319-20. PubMed ID: 21130538 [No Abstract] [Full Text] [Related]
19. Management of complicated infections in the era of antimicrobial resistance: the role of tigecycline. Nicolau DP Expert Opin Pharmacother; 2009 May; 10(7):1213-22. PubMed ID: 19405794 [TBL] [Abstract][Full Text] [Related]
20. Tigecycline : a critical safety review. Kaewpoowat Q; Ostrosky-Zeichner L Expert Opin Drug Saf; 2015 Feb; 14(2):335-42. PubMed ID: 25539800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]